Other papers submitted by: Dr Elena Galve-Calvo

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Elena Galve-Calvo

Paper published by Dr Elena Galve-Calvo:

Original Research

Highly-accessed

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain

Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A

ClinicoEconomics and Outcomes Research 2018, 10:773-790

Published Date: 14 November 2018